rethinkTHC Search
Menu
Study breakdown

How Cannabis Triggers Psychosis Through the Brain's Endocannabinoid System

Narrative ReviewModerate evidence
The takeaway

A review of the past decade of research found cannabis use increases psychosis risk through disruption of the endocannabinoid system during adolescent brain development, affecting synaptic pruning and dopamine/glutamate signaling.

Psychiatrists, neuroscientists, and anyone concerned about cannabis and mental health

Cannabis disrupts endocannabinoid-mediated synaptic pruning during adolescence

What the researchers found

Earlier age of cannabis use onset, genetic predisposition, and heavy/high-potency use all independently increase psychosis risk. The mechanism involves the endocannabinoid system, which regulates synaptic pruning during adolescence. Cannabis disrupts this process and alters glutamate and dopamine neurotransmission. Pre-existing endocannabinoid system dysfunction in people with schizophrenia vulnerability is further worsened by cannabis.

Why it matters

Understanding the biological mechanism by which cannabis triggers psychosis (not just the epidemiological association) is essential for identifying who is most at risk and developing prevention strategies. The endocannabinoid system disruption model provides that mechanistic link.

The numbers in context

Reviewed 10 years of literature. Key risk factors: early age of use, genetic predisposition, heavy use, high-potency cannabis. Mechanisms: disrupted synaptic pruning, altered dopamine and glutamate signaling, worsened endocannabinoid system dysfunction.

How the study worked

Narrative review of PubMed literature from the past 10 years using keywords "cannabis use, psychosis, schizophrenia, endocannabinoid system, pathophysiology, neurobiology."

What this study cannot tell us

Narrative review without systematic methodology. Much of the mechanistic evidence comes from animal studies that may not fully translate to humans. The review focuses on risk but does not quantify absolute risk levels.

How to read the evidence

Comprehensive narrative review integrating epidemiological and neurobiological evidence, though non-systematic.

When this study was published

2024 review

The bigger picture

The convergence of epidemiological and neurobiological evidence makes the cannabis-psychosis link one of the strongest in psychiatric research. This review argues the case has moved beyond association to plausible biological mechanism.

Questions still open

  • Can endocannabinoid system biomarkers identify individuals at highest risk? Would CBD counteract the psychosis-promoting effects of THC? Could targeted interventions during adolescence protect the endocannabinoid system?

Common questions

How does cannabis cause psychosis?
This review explains that cannabis disrupts the endocannabinoid system during adolescent brain development, interfering with synaptic pruning and altering dopamine and glutamate signaling, which can trigger psychotic symptoms in vulnerable individuals.
Who is most at risk for cannabis-induced psychosis?
People who start using cannabis earlier in adolescence, those with genetic predisposition (family history of psychosis), and heavy users of high-potency cannabis are at highest risk.

Read the original research

The Role of Cannabis in the Development of Psychosis.

Turk psikiyatri dergisi = Turkish journal of psychiatry, 35(3), 234-244

Citation

Türkoğlu, Özge; Ertuğrul, Aygün. (2024). The Role of Cannabis in the Development of Psychosis.. Turk psikiyatri dergisi = Turkish journal of psychiatry, 35(3), 234-244. https://doi.org/10.5080/u27122

Explore the wider topic